A detailed history of Tower Research Capital LLC (Trc) transactions in Nexalin Technology, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 9,870 shares of NXL stock, worth $28,919. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,870
Previous 9,079 8.71%
Holding current value
$28,919
Previous $12,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.61 - $2.96 $482 - $2,341
791 Added 8.71%
9,870 $16,000
Q1 2024

May 15, 2024

BUY
$0.3 - $1.4 $2 - $11
8 Added 0.09%
9,079 $12,000
Q4 2023

Feb 13, 2024

BUY
$0.28 - $0.52 $1 - $2
5 Added 0.06%
9,071 $3,000
Q3 2023

Nov 14, 2023

BUY
$0.38 - $0.95 $1 - $3
4 Added 0.04%
9,066 $3,000
Q2 2023

Aug 14, 2023

SELL
$0.72 - $0.92 $4 - $5
-6 Reduced 0.07%
9,062 $8,000
Q1 2023

May 09, 2023

BUY
$0.75 - $1.22 $610 - $993
814 Added 9.86%
9,068 $7,000
Q4 2022

Feb 10, 2023

BUY
$0.74 - $2.39 $6,107 - $19,727
8,254 New
8,254 $6,000

Others Institutions Holding NXL

About Nexalin Technology, Inc.


  • Ticker NXL
  • Exchange
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 7,279,960
  • Market Cap $21.3M
More about NXL
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.